AzurRx engages CROs Rho and Linical in separate Phase II trials in cystic fibrosis with pancreatic insufficiency
AzurRx BioPharma is working with CROs Rho and Linical for its Phase II and Phase IIb MS1819 trials, respectively, in cystic…
AzurRx BioPharma is working with CROs Rho and Linical for its Phase II and Phase IIb MS1819 trials, respectively, in cystic…
Revitope Oncology will be open to CRO and CMO pitches in a couple of months for a Phase I trial after it selects its development candidate, said Chief Scientific Officer…
Novavax’s South Africa-based Phase IIb trial investigating its COVID-19 vaccine NVX-CoV2373 has results likely to be revealed within the next fortnight, a source familiar with the trial said. The company…
On 8 January, Biogen announced that the first spinal muscular atrophy (SMA) patient had been treated in its Phase IV RESPOND study evaluating the efficacy and safety of Spinraza (nusinersen)…
On January 7, Teva Pharmaceuticals and MedinCell announced positive results from their Phase III trial (RISE Study) evaluating mdc-IRM (risperidone) as a maintenance treatment in adults and adolescents with schizophrenia.…
RenovoRx is receptive to investor pitches for an ongoing $10m-$20m Series C, which will fund the company up to an interim analysis of its Phase III trial for pancreatic cancer…
The prevention of venous thromboembolism is one of many priorities in managing Covid-19 patients, but there are several complex considerations, especially when examining preventive strategies for those being managed as…